Home › Funds › Castleview Partners, LLC › AMGN

Castleview Partners, LLC position in AMGN

AMGEN INC · Health Care

Castleview Partners, LLC reported holding 11,160 shares of AMGN (AMGEN INC) in its Q3 2026 13F filing — a position valued at US$4.7M, representing 2.06% of its reported portfolio and ranking #11 among its reported holdings. Castleview Partners, LLC has disclosed AMGN holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)11.16K sh
Reported value held$4.70M
Portfolio Weight2.06%
First reportedQ3 2023
Last changeAdd
Updated2026-10-10

Last updated: 2026-10-10 · Source: SEC EDGAR Form 13F-HR

How Castleview Partners, LLC's AMGN position evolved

Castleview Partners, LLC first disclosed a stake in AMGN in Q3 2023 at 2,411 shares (US$648K). The position peaked in Q3 2026 at 11,160 shares, worth US$4.7M. Across 13 filings, Castleview Partners, LLC increased the stake 9 time(s), trimmed it 3 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 11,160 shares valued at US$4.7M — an increase of 608 shares quarter over quarter.. Notable position changes include a 230% increase in Q1 2024 (shares rose 10% over the following quarter), a 38% trim in Q1 2026 (shares rose 3% over the following quarter), a 34% increase in Q2 2026 (shares rose 16% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 2.41K $647.99K New
Q4 2023 2.88K $828.63K Add
Q1 2024 9.50K $2.70M Add
Q2 2024 9.69K $3.03M Add
Q3 2024 11.56K $3.73M Add
Q4 2024 10.85K $2.81M Reduce
Q1 2025 13.15K $4.10M Add
Q2 2025 10.64K $2.97M Reduce
Q3 2025 11.68K $3.29M Add
Q4 2025 12.62K $4.13M Add
Q1 2026 7.86K $2.77M Reduce
Q2 2026 10.55K $3.82M Add
Q3 2026 11.16K $4.70M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About AMGN and 13F data

AMGN (AMGEN INC) is a Health Care company. 32 other funds we track also report a position in AMGN — the largest reported positions include BlackRock Inc (US$17.87B), STATE STREET CORP (US$10.75B), Capital World Investors (US$10.53B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding AMGN

All AMGN fund holders →

FAQ

How long has Castleview Partners, LLC held AMGN?

Castleview Partners, LLC has disclosed AMGN holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Castleview Partners, LLC's current position in AMGN?

As of Q3 2026, Castleview Partners, LLC holds 11.16K shares of AMGN (AMGEN INC), valued at $4.70M, representing 2.06% of its reported portfolio and ranking #11.

Has Castleview Partners, LLC been buying or selling AMGN?

In the latest 13F filing (Q3 2026), Castleview Partners, LLC increased its position in AMGN. The position peaked in Q3 2026 at 11.16K shares.

Which other funds hold AMGN?

Other major institutional holders of AMGN include BlackRock Inc, STATE STREET CORP, Capital World Investors, among 32 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.